ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Colorado » Internal Medicine

Top Internal Medicine Prescribers in Colorado

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
PETER WOLSKO MD

Internal Medicine

8,123

$423K

671
597 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

11%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$52
Average prescription price

Avg: $56

GREGORY DILORENZO D.O

Internal Medicine

8,122

$475K

418
366 are 65+

8%
patients receiving schedule two controlled substances

Avg: 8%

13%
patients receiving schedule three controlled substances

Avg: 9%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$59
Average prescription price

Avg: $56

DAVID CONWAY MD

Internal Medicine

8,118

$558K

472
423 are 65+

5%
patients receiving schedule two controlled substances

Avg: 8%

6%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$69
Average prescription price

Avg: $56

GRACE NWEKE MD

Internal Medicine

8,088

$644K

279
117 are 65+

16%
patients receiving schedule two controlled substances

Avg: 8%

18%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 24%

$80
Average prescription price

Avg: $56

GERALD BROWN MD

Internal Medicine

8,065

$554K

547
505 are 65+

4%
patients receiving schedule two controlled substances

Avg: 8%

6%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 24%

$69
Average prescription price

Avg: $56

TREVOR CLAYBORN MD

Internal Medicine

8,050

$374K

676
597 are 65+

13%
patients receiving schedule two controlled substances

Avg: 8%

12%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$47
Average prescription price

Avg: $56

FEDERICO SALVO SOTO MD

Internal Medicine

8,043

$484K

435
325 are 65+

8%
patients receiving schedule two controlled substances

Avg: 8%

11%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$60
Average prescription price

Avg: $56

ROBERT BLAYNEY MD

Internal Medicine

8,030

$332K

202
192 are 65+

22%
patients receiving schedule two controlled substances

Avg: 8%

12%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$41
Average prescription price

Avg: $56

VINCENT BILELLO M.D.

Internal Medicine

7,995

$379K

688
614 are 65+

10%
patients receiving schedule two controlled substances

Avg: 8%

9%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$47
Average prescription price

Avg: $56

JEFFREY GORI MD

Internal Medicine

7,986

$332K

558
504 are 65+

6%
patients receiving schedule two controlled substances

Avg: 8%

7%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$42
Average prescription price

Avg: $56

MICHAEL GUESE

Internal Medicine

7,965

$609K

423
394 are 65+

4%
patients receiving schedule two controlled substances

Avg: 8%

11%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$76
Average prescription price

Avg: $56

ROBERT REEVES M.D.

Internal Medicine

7,949

$393K

432
407 are 65+

4%
patients receiving schedule two controlled substances

Avg: 8%

15%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $56

LAURA CLARK MD

Internal Medicine

7,921

$275K

660
608 are 65+

8%
patients receiving schedule two controlled substances

Avg: 8%

7%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$35
Average prescription price

Avg: $56

JOSHUA BRAUER MD

Internal Medicine

7,912

$344K

957
853 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

8%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$44
Average prescription price

Avg: $56

NICOLE JOSEPH MD

Internal Medicine

7,845

$262K

367
172 are 65+

23%
patients receiving schedule two controlled substances

Avg: 8%

13%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$33
Average prescription price

Avg: $56

DOUGLAS MCCALLUM M.D.

Internal Medicine

7,830

$335K

406
378 are 65+

4%
patients receiving schedule two controlled substances

Avg: 8%

11%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$43
Average prescription price

Avg: $56

JEANNINE WALLNUTT MD

Internal Medicine

7,815

$333K

655
587 are 65+

12%
patients receiving schedule two controlled substances

Avg: 8%

12%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$43
Average prescription price

Avg: $56

CHRISTOPHER HICKS MD

Internal Medicine

7,812

$288K

684
599 are 65+

8%
patients receiving schedule two controlled substances

Avg: 8%

11%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$37
Average prescription price

Avg: $56

HEATHER BURTON MD

Internal Medicine

7,780

$312K

567
522 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

7%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$40
Average prescription price

Avg: $56

RICHARD GOOD MD

Internal Medicine

7,773

$606K

587
543 are 65+

5%
patients receiving schedule two controlled substances

Avg: 8%

8%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 24%

$78
Average prescription price

Avg: $56

REBECCA AGNEW M.D.

Internal Medicine

7,772

$320K

595
502 are 65+

15%
patients receiving schedule two controlled substances

Avg: 8%

17%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$41
Average prescription price

Avg: $56

PRECIOUS CASTRO-FLORES MD

Internal Medicine

7,769

$511K

326
232 are 65+

20%
patients receiving schedule two controlled substances

Avg: 8%

18%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$66
Average prescription price

Avg: $56

KAREN KELLY M.D.

Internal Medicine

7,757

$439K

549
487 are 65+

3%
patients receiving schedule two controlled substances

Avg: 8%

5%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$57
Average prescription price

Avg: $56

KEVIN MOLK M.D.

Internal Medicine

7,723

$750K

554
507 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

6%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 24%

$97
Average prescription price

Avg: $56

WILLIAM ELZI MD

Internal Medicine

7,691

$470K

806
705 are 65+

9%
patients receiving schedule two controlled substances

Avg: 8%

8%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$61
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank